Skip to main content

Demonstrate the Economic Value of Your Technology

Quantify costs, outcomes and budget impact to strengthen market access decisions.

Learn more

White Paper: Health Economic Evidence Requirements for Medical Devices in Europe

Get insights from MTRC White Papers to discover health economic evidence requirements and best practices for market access in the EU5

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Health Economic Publication Digest: Health economic evaluations of digital health technologies – a rapid review of applied methods

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. 

In a recent publication, Campione et al. reviewed methods applied in economic evaluations of digital health technologies (DHT) published between 2020 and 2024. The authors identified 51 eligible studies, most of which were based on randomized controlled trials and used established economic evaluation approaches originally developed for non-digital health interventions. The findings identified substantial variation in study perspectives, cost categories, uncertainty assessment, and reporting quality, alongside limited transparency and potential bias in the underlying evidence. DHT-specific factors, including technology life cycles and transferability across user groups, were also rarely considered.

Access the full-text article here.